1115 Results (Page 22 of 45)
Medical Devices Markets Research Reports
Mexico Diabetes Devices Market Analysis
The Mexico Diabetes Devices Market is expected to witness growth from $341 Mn in 2022 to $606 Mn in 2030 with a CAGR of 7.45% for the forecasted year 2022-2030. The demand for diabetes devices is rising as the Mexican population's discretionary income rises. As the economy improves and the middle class grows, this tendency is anticipated to persist. The market is segmented by type and by the end user. Some key players in this market include Famous Tijuana, Medstent, Medyssey, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Turkey Diabetes Devices Market Analysis
The Turkey Diabetes Devices Market is expected to witness growth from $182 Mn in 2022 to $329 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-2030. Affordable healthcare options, reasonably lax regulatory requirements, and cost-effective labour are a few of the factors driving diabetic device manufacturers to grow their businesses in Turkey. The market is segmented by type and by the end user. Some key players in this market include Megasan Medikal, Kare Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Tanzania Diabetes Devices Market Analysis
The Tanzania Diabetes Devices Market is expected to witness growth from $9 Mn in 2022 to $17 Mn in 2030 with a CAGR of 8.10 % for the forecasted year 2022-2030. Tanzania's healthcare infrastructure has recently undergone improvements, including the development of medical facilities and the accessibility of qualified medical professionals. This improves diabetes patients’ access to diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Spain Diabetes Devices Market Analysis
The Spain Diabetes Devices Market is expected to witness growth from $439 Mn in 2022 to $710 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In Spain, diabetes instances have been steadily increasing in recent years. This tendency, which is anticipated to continue, will lead to an increase in the market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Medlumics, Ekuore, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Poland Diabetes Devices Market Analysis
The Poland Diabetes Devices Market is expected to witness growth from $132 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.65% for the forecasted year 2022-2030. Diabetes is more common in older people, so demand for diabetes devices is anticipated to increase as Poland's population ages. The market is segmented by type and by the end user. Some key players in this market include Skamex, SORIMEX, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Netherlands Diabetes Devices Market Analysis
The Netherlands Diabetes Devices Market is expected to witness growth from $59 Mn in 2022 to $107 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-2030. There has been a consistent rise in the number of diabetes diagnoses in the Netherlands. Manufacturers of diabetes devices now have a great chance to meet the rising demand for diabetes management solutions. The market is segmented by type and by the end user. Some key players in this market include Hy2Care B.V, InnoSer, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V, Roche and Dexcom.
Italy Diabetes Devices Market Analysis
The Italy Diabetes Devices Market is expected to witness growth from $546 Mn in 2022 to $916 Mn in 2030 with a CAGR of 6.70% for the forecasted year 2022-2030. In Italy, the number of cases of diabetes has been gradually rising in recent years. The market for diabetes devices and associated goods will increase as a result of this trend. The market is segmented by type and by the end user. Some key players in this market include Ormesa S.R.L, Angelantoni Life Science, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
US Coronary Stents Market Analysis
The US coronary stents market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. The US coronary stents market is driven by several factors, including the high prevalence of coronary artery disease (CAD) in the US, advances in stent technology, and increasing demand for minimally invasive procedures. The market is highly competitive, with several major players such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic dominating the market. These companies invest heavily in research and development to develop innovative stent technologies that provide better outcomes for patients.
US Biomaterials in Healthcare Market Analysis
The US biomaterials in the healthcare market are projected to grow from $65.6 Bn in 2022 to $153.4 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-30. Chronic diseases such as cardiovascular disease, cancer, and diabetes are on the rise in the US. The market is highly competitive, with several key players, including BASF SE, DSM NV, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, and Royal DSM. These companies invest heavily in research and development to develop new biomaterials and improve the performance of existing ones.
Germany Diabetes Devices Market Analysis
The Germany Diabetes Devices Market is expected to witness growth from $832 Mn in 2022 to $1267 Mn in 2030 with a CAGR of 5.40% for the forecasted year 2022-2030. The demand for diabetes devices is being driven by the high and rising incidence of diabetes in Germany. The market is segmented by type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
France Diabetes Devices Market Analysis
The France Diabetes Devices Market is expected to witness growth from $625 Mn in 2022 to $1011 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In France, insulin pumps have become increasingly popular due to their ability to improve glycemic control and enhance the quality of life for diabetes patients in France. Manufacturers that offer insulin pumps with advanced features and better usability are likely to see growth in the market. The market is segmented by type and by the end user. Some key players in this market include Nanosonics France, SAMMEX Medical, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
China Diabetes Devices Market Analysis
The China Diabetes Devices Market is expected to grow from $1.82 Bn in 2022 to $3.56 Bn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. Diabetes is a common condition in China, where the demand for diabetes-related products and devices is rising. The prevalence of diabetes is anticipated to increase as the population ages and urbanizes, providing significant opportunities for diabetes device manufacturers. The market is segmented by type and by the end user. Some key players in this market include Lepu Medical Technology, MicroPort, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
US Cardiac Monitoring Devices Market Analysis
The US cardiac monitoring device market is projected to grow from $12.1 Bn in 2022 to $15 Bn by 2030, registering a CAGR of 2.7% during the forecast period of 2022-30. The US cardiac monitoring device market is expected to continue growing as the demand for accurate and reliable Cardiac Monitoring devices increases. Medtronic is a leading medical device company that offers a range of cardiac monitoring devices, including implantable cardiac monitors, pacemakers, and defibrillators.
US ENT Devices Market Analysis
The US ENT devices market is projected to grow from $9.7 Bn in 2022 to $13.1 Bn by 2030, registering a CAGR of 3.75% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. According to the National Institute on Deafness and Other Communication Disorders, approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the market include Cochlear Limited, William Demant Holding A/S, Medtronic plc, Stryker Corporation, and Olympus Corporation.
UAE Cardiac Surgery Instruments Market Analysis
The UAE Cardiac Surgery Instruments Market is expected to witness growth from $10 Mn in 2022 to $19 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The UAE has gained popularity as a destination for medical tourism, especially among patients seeking high-quality treatment at a lower cost. As a result, there is now greater demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Gulf Scientific Al Mazroui Medical and Chemical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Thailand Cardiac Surgery Instruments Market Analysis
The Thailand Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $4 Mn in 2030 with a CAGR of 6.94% for the forecasted year 2022-2030. Thailand has an advantageous business climate due to its friendly government policies, affordable labour, and competent labour force. As a result, many manufacturers have established operations in the country to take advantage of the expanding market for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include Xovic, Meticuly, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Tanzania Cardiac Surgery Instruments Market Analysis
The Tanzania Cardiac Surgery Instruments Market is expected to witness growth from $0.8 Mn in 2022 to $1.5 Mn in 2030 with a CAGR of 7.50% for the forecasted year 2022-2030. Tanzania has a significant incidence and prevalence of ischemic heart disease and rheumatic heart disease. The country's demand for cardiac surgery instruments is anticipated to increase due to the rising prevalence of these illnesses. The market is segmented by type, application and by end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
South Africa Cardiac Surgery Instruments Market Analysis
The South Africa Cardiac Surgery Instruments Market is expected to witness growth from $13 Mn in 2022 to $25 Mn in 2030 with a CAGR of 7.83% for the forecasted year 2022-2030. Increase in the prevalence of Coronary Artery Disease (CAG) in South Africa. As more patients need surgical procedures to control their conditions, this is increasing demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include SSEM Mthembu Medical, NuAngle Medical, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Singapore Cardiac Surgery Instruments Market Analysis
The Singapore Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $4 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. Cardiovascular conditions such as coronary artery disease, heart failure, and arrhythmias are becoming more prevalent in Singapore due to factors such as the ageing population, sedentary lifestyles, and unhealthy diets. As a result, there is now greater demand for the tools and techniques used in heart surgery. The market is segmented by type, application and by end user. Some key players in this market include Biosensors International, Inzign Pte, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Saudi Arabia Cardiac Surgery Instruments Market Analysis
The Saudi Arabia Cardiac Surgery Instruments Market is expected to witness growth from $35 Mn in 2022 to $66 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Saudi Arabia, the incidence of cardiovascular diseases such as coronary heart disease, stroke, and hypertension is rising. In order to diagnose, treat, and control these conditions, cardiac surgery equipment is in high demand. The market is segmented by type, application and by end user. Some key players in this market include Al Madar Medical, Aljeel Medical, Alhammad medical, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Romania Cardiac Surgery Instruments Market Analysis
The Romania Cardiac Surgery Instruments Market is expected to witness growth from $6 Mn in 2022 to $10 Mn in 2030 with a CAGR of 6.85% for the forecasted year 2022-2030. Patients from different countries are travelling to Romania for cardiac surgeries, making it an increasingly popular location for medical tourism. The demand for high-quality cardiac surgery instruments is expected to increase as a result of this tendency. The market is segmented by type, application and by end user. Some key players in this market include BioSintex, Trident Medical Company S.R.L, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Poland Cardiac Surgery Instruments Market Analysis
The Poland Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 7.05% for the forecasted year 2022-2030. Cardiovascular diseases are becoming more prevalent in Poland as the country's populace increases. Additionally, the older population has more complicated health problems, which increases the demand for cardiac surgery instruments in Poland. The market is segmented by type, application and by end user. Some key players in this market include Metrum Cryoflex, Skamex, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Nigeria Cardiac Surgery Instruments Market Analysis
The Nigeria Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $3 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. The market for instruments used in cardiac surgery is significantly influenced by the elevated rate of heart disease in Nigeria. The market is segmented by type, application and by end user. Some key players in this market include JNC International, GBioMed Nigeria, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Netherlands Cardiac Surgery Instruments Market Analysis
The Netherlands Cardiac Surgery Instruments Market is expected to witness growth from $5 Mn in 2022 to $9 Mn in 2030 with a CAGR of 7.10% for the forecasted year 2022-2030. The demand for cardiac surgery instruments is anticipated to rise in the Netherlands as a result of a growing elderly population and the rising incidence of cardiovascular illnesses. The market is segmented by type, application and by end user. Some key players in this market include Hy2Care B.V, InnoSer, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Mexico Cardiac Surgery Instruments Market Analysis
The Mexico Cardiac Surgery Instruments Market is expected to witness growth from $31 Mn in 2022 to $53 Mn in 2030 with a CAGR of 6.85% for the forecasted year 2022-2030. Heart failure and coronary artery disease are two rising health concerns in Mexico. The overall incidence of these illnesses is anticipated to rise as the population grows and lifestyles change, fueling demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include BIOMEDICA MEXICANA, Medstent, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.